The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10739 malaria professionals are enjoying the free benefits of MalariaWorld today

plasmodium yoelii

Differential Immune Response Associated to Malaria Outcome Is Detectable in Peripheral Blood following Plasmodium yoelii Infection in Mice

February 4, 2014 - 18:42 -- Open Access
Author(s): 
Isabel G. Azcárate, Patricia Marín-García, Alí N. Kamali, Susana Pérez-Benavente, Antonio Puyet, Amalia Diez, José M. Bautista
Reference: 
PLoS ONE 9(1): e85664

Here, we present a mouse model in which a heterogeneous course of Plasmodium yoelii lethal malaria infection is produced in a non-congenic ICR strain to allow comparison among different immunological and clinical outcomes.

Reticulocyte-prone malaria parasites predominantly invade CD71hi immature cells: implications for the development of an in vitro culture for Plasmodium vivax

December 4, 2013 - 06:57 -- Open Access
Author(s): 
Martín-Jaular L, Elizalde-Torrent A, Thomson-Luque R, Ferrer M, Segovia JC, Herreros-Aviles E, Fernández-Becerra C, del Portillo HA
Reference: 
Malaria Journal 2013, 12 :434 (1 December 2013)
MalariaWorld

The parasite preference for immature cells that are rare in normal peripheral blood could have important implications for the development of an in vitro culture system for P. vivax.

NOT Open Access | Inactivation of Plasmodium spp. in plasma and platelet concentrates using riboflavin and ultraviolet light

October 9, 2013 - 07:20 -- NOT Open Access
Author(s): 
Shawn D. Keil, Patti Kiser, James J. Sullivan, Amy S. Kong, Heather L. Reddy, Anne Avery and Raymond P. Goodrich
Reference: 
Transfusion, Volume 53, Issue 10, pages 2278–2286, October 2013
MalariaWorld

Treatment with riboflavin and UV light was effective at reducing viable P. falciparum in both PLT and plasma products by at least 3.2 logs. Additionally, an at least 4.4-log reduction was observed with P. yoelii.

Molecular Analysis of Non-Specific Protection against Murine Malaria Induced by BCG Vaccination

July 19, 2013 - 13:29 -- Open Access
Author(s): 
Marcela Parra, Xia Liu, Steven C. Derrick, Amy Yang, Jinhua Tian, Kristopher Kolibab, Sanjai Kumar, Sheldon L. Morris
Reference: 
PLoS ONE 8(7): e66115
MalariaWorld

Although the effectiveness of BCG vaccination in preventing adult pulmonary tuberculosis (TB) has been highly variable, epidemiologic studies have suggested that BCG provides other general health benefits to vaccinees including reducing the impact of asthma, leprosy, and possibly malaria.

Not Open Access | Total and Putative Surface Proteomics of Malaria Parasite Salivary Gland Sporozoites

May 10, 2013 - 17:54 -- NOT Open Access
Author(s): 
Scott E. Lindner, Kristian E. Swearingen, Anke Harupa, Ashley M. Vaughan, Photini Sinnis, Robert L. Moritz, and Stefan H. I. Kappe
Reference: 
Molecular & Cellular Proteomics, 12, 1127-1143. May 1, 2013
MalariaWorld

Here we describe the proteomic profiling of highly purified salivary gland sporozoites from two Plasmodium species: human-infective Plasmodium falciparum and rodent-infective Plasmodium yoelii. 

The Role of Serine-Type Serine Repeat Antigen in Plasmodium yoelii Blood Stage Development

May 8, 2013 - 06:39 -- Open Access
Author(s): 
Ximei Huang, Kingsley Liew, Onguma Natalang, Anthony Siau, Neng Zhang, Peter Rainer Preiser
Reference: 
PLoS ONE 8(4): e60723
MalariaWorld

A key step for the survival of the malaria parasite is the release from and subsequent invasion of erythrocytes by the merozoite.

Quantitative Bioluminescent Imaging of Pre-Erythrocytic Malaria Parasite Infection Using Luciferase-Expressing Plasmodium yoelii

April 22, 2013 - 12:34 -- Open Access
Author(s): 
Jessica L. Miller, Sara Murray, Ashley M. Vaughan, Anke Harupa, Brandon Sack, Michael Baldwin, Ian N. Crispe, Stefan H. I. Kappe
Reference: 
PLoS ONE 8(4): e60820.
MalariaWorld

The liver stages of Plasmodium parasites are important targets for the development of anti-malarial vaccine candidates and chemoprophylaxis approaches that aim to prevent clinical infection.

NOT Open Access | Ketoconazole, a cytochrome P450 inhibitor can potentiate the antimalarial action of α/β arteether against MDR Plasmodium yoelii nigeriensis

March 27, 2013 - 08:35 -- NOT Open Access
Author(s): 
Renu Tripathi, Amber Rizvi, Swaroop Kumar Pandey, Hemlata Dwivedi, J.K. Saxena
Reference: 
Acta Tropica, Volume 126, Issue 2, May 2013, Pages 150–155
MalariaWorld

The emergence of multidrug resistant (MDR) strains of Plasmodium falciparum in South East Asia and other tropical countries, is posing serious challenge for the international efforts to eradicate malaria.

NOT Open Access | Biological assay of a novel quinoxalinone with antimalarial efficacy on Plasmodium yoelii yoelii

March 19, 2013 - 11:24 -- NOT Open Access
Author(s): 
Norma Rivera, Yovani Marrero Ponce, Vicente J. Arán, Cecilia Martínez & Filiberto Malagón
Reference: 
Parasitology Research, April 2013, Volume 112, Issue 4, pp 1523-1527
MalariaWorld

Compound 1-methyl-7-nitro-4-(5-(piperidin-1-yl)pentyl)-3,4-dihydroquinoxalin-2(1H)-one (VAM2-6) was evaluated against a blood-induced infection with chloroquine-sensitive Plasmodium yoelii yoelii lethal strain in CD1 mice in a 4-day test scheme.

Medical Treatment: 

NOT Open Access | Outcome of primary lethal and nonlethal Plasmodium yoelii malaria infection in BALB/c and IFN-γ receptor-deficient mice following chloroquine treatment

February 1, 2013 - 09:08 -- NOT Open Access
Author(s): 
Akira Ishih, Chiri Kawakami, Atsuko Todoroki, Hiroya Hirai, Kaneo Ohori & Fumie Kobayashi
Reference: 
Parasitology Research, February 2013, Volume 112, Issue 2, pp 773-780
MalariaWorld

IFN-γ receptor-deficient (IFN-γR−/−) mice and control wild-type (WT) mice, with or without chloroquine (CQ) treatment, were infected intraperitoneally with Plasmodium yoelii 17XL (lethal) and P. yoelii 17XNL (nonlethal), and then mouse survival, parasitemia, and antibody production were investigated during the course of infection.

Pages

Subscribe to RSS - plasmodium yoelii